Advanced Search

    Technical Analysis for SNOA - Sonoma Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 1.66 1.45% 0.02
    SNOA closed up 0.61 percent on Friday, February 3, 2023, on 10 percent of normal volume.
    Earnings due: Feb 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical SNOA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 1.45%
    Calm After Storm Range Contraction 2.07%
    NR7 Range Contraction 2.07%
    Narrow Range Bar Range Contraction 2.07%
    Wide Bands Range Expansion 2.07%
    Gapped Up Strength 2.07%
    Down 3 Days in a Row Weakness 2.07%
    Down 4 Days in a Row Weakness 2.07%
    180 Bullish Setup Bullish Swing Setup 0.83%
    Calm After Storm Range Contraction 0.83%
    Older End-of-Day Signals for SNOA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    60 Minute Opening Range Breakout about 2 hours ago
    Possible NR7 about 3 hours ago
    Possible Inside Day about 3 hours ago
    Down 2 % about 3 hours ago
    Up 1% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Animal Health Sonoma

    Is SNOA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 31 Sonoma stock surges ~15% on distribution pact with Daewoong in South Korea
    Jan 31 Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
    Jan 25 Sonoma stock soars ~90% on product registration enabling sale to US government
    Jan 25 Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
    Jan 4 Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas
    Nov 17 Sonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022)
    Nov 15 Sonoma Pharmaceuticals GAAP EPS of -$0.33, revenue of $3.3M
    Nov 14 Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results
    Nov 4 Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
    Nov 2 Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
    See more SNOA news...

    Indicators

    Indicator Value
    52 Week High 4.25
    52 Week Low 1.0
    Average Volume 2,285,670
    200-Day Moving Average 2.45
    50-Day Moving Average 1.41
    20-Day Moving Average 1.42
    10-Day Moving Average 1.63
    Average True Range 0.21
    RSI 57.08
    ADX 35.87
    +DI 36.61
    -DI 11.41
    Chandelier Exit (Long, 3 ATRs) 2.03
    Chandelier Exit (Short, 3 ATRs) 1.72
    Upper Bollinger Bands 1.97
    Lower Bollinger Band 0.87
    Percent B (%b) 0.7
    BandWidth 77.17
    MACD Line 0.10
    MACD Signal Line 0.06
    MACD Histogram 0.0374
    Fundamentals Value
    Market Cap 3.35 Million
    Num Shares 2.04 Million
    EPS -7.06
    Price-to-Earnings (P/E) Ratio -0.23
    Price-to-Sales 0.59
    Price-to-Book 1.18
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.81
    Resistance 3 (R3) 1.81 1.75 1.78
    Resistance 2 (R2) 1.75 1.71 1.75 1.77
    Resistance 1 (R1) 1.70 1.69 1.73 1.70 1.76
    Pivot Point 1.64 1.64 1.66 1.64 1.64
    Support 1 (S1) 1.59 1.60 1.61 1.58 1.52
    Support 2 (S2) 1.53 1.57 1.53 1.51
    Support 3 (S3) 1.47 1.53 1.50
    Support 4 (S4) 1.47